Lymphadenopathy clinical trials

Explore recruiting lymphadenopathy clinical trials.

Recruiting lymphadenopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphadenopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Interest of Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis: a randomized controlled study. "BIGG" : Bartonellosis and intra-nodal injection of gentamicin

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) (POLARIS-1)

Hungary, France, Romania, Czechia, Italy, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

European Randomised Clinical Trial on mPOX Infection (EPOXI)

Netherlands, France, Portugal, Germany, Belgium, Spain +2 more

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Randomized, Open-Label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination with Reduced-Intensity Chemotherapy, in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Spain, Italy, Austria, Poland, Greece, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lymphadenopathy trials by city

Lymphadenopathy in Toronto Lymphadenopathy in Vancouver Lymphadenopathy in Montreal Lymphadenopathy in Calgary Lymphadenopathy in Edmonton Lymphadenopathy in Ottawa Lymphadenopathy in Winnipeg Lymphadenopathy in Quebec City Lymphadenopathy in Hamilton Lymphadenopathy in Kitchener Lymphadenopathy in London Lymphadenopathy in Halifax Lymphadenopathy in New York Lymphadenopathy in Los Angeles Lymphadenopathy in Chicago Lymphadenopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease